Effects of Paclitaxel and Gemcitabine on Lung Cancer Cells
Author Information
Author(s): Kroep J R, Giaccone G, Tolis C, Voorn D A, Loves W J P, Groeningen C J van, Pinedo H M, Peters G J
Primary Institution: Department of Medical Oncology, University Hospital Vrije Universiteit
Hypothesis
The sequence of administering paclitaxel and gemcitabine affects their cytotoxicity in non-small-cell lung cancer cell lines.
Conclusion
The study found that while various combinations of gemcitabine and paclitaxel did not show sequence-dependent cytotoxic effects, administering paclitaxel before gemcitabine may be more beneficial.
Supporting Evidence
- Gemcitabine caused S and G1 phase arrest at certain concentrations.
- Paclitaxel induced G2/M arrest which was maximal at 10 × IC-50.
- Simultaneous treatment increased S-phase arrest.
- Apoptosis was more pronounced when paclitaxel was given before gemcitabine.
- Paclitaxel increased the accumulation of dFdCTP in H460 cells.
- Gemcitabine almost completely inhibited DNA synthesis in both cell lines.
Takeaway
This study looked at how two cancer drugs work together in lung cancer cells, finding that the order in which they are given can change how well they work.
Methodology
The study used DNA flow cytometry and multiple drug effect analysis on NSCLC cell lines.
Statistical Information
P-Value
0.051
Statistical Significance
p=0.051
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website